NCT00004002View on ClinicalTrials.gov

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

October 31, 2001

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Trial Locations (5)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00004002 - PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter